Remdesivir expected to remain effective against omicron variant, Gilead says
Remdesivir targets the viral RNA polymerase in order to prevent replication of SARS-CoV-2 inside infected cells. In addition to genetic analyses, Gilead continues to evaluate remdesivir through in vitro antiviral testing.
from Google Alert - Business https://ift.tt/3xKw00r
Remdesivir targets the viral RNA polymerase in order to prevent replication of SARS-CoV-2 inside infected cells. In addition to genetic analyses, Gilead continues to evaluate remdesivir through in vitro antiviral testing. https://ift.tt/eA8V8J
from Google Alert - Business https://ift.tt/3xKw00r
Remdesivir targets the viral RNA polymerase in order to prevent replication of SARS-CoV-2 inside infected cells. In addition to genetic analyses, Gilead continues to evaluate remdesivir through in vitro antiviral testing. https://ift.tt/eA8V8J
Comments
Post a Comment